Antiviral responses in mouse embryonic stem cells: Differential development of cellular mechanisms in type I interferon production and response

Journal of Biological Chemistry

Volumn 289, Issue 36, 2014, Pages 25186-25198

  Wang, Ruoxing ^a   Wang, Jundi ^a   Acharya, Dhiraj ^a   Paul, Amber M ^a   Bai, Fengwei ^a   Huang, Faqing ^a   Guo, Yan Lin ^a  

^a The University of Southern Mississippi   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CELL CULTURE; GENES; GLYCOPROTEINS; INTERFERONS; MAMMALS; TISSUE; VIRUSES;

ANTIVIRAL ACTIVITIES; ANTIVIRAL RESPONSE; CELLULAR MECHANISMS; DIFFERENTIAL DEVELOPMENT; MOLECULAR MECHANISM; MOUSE EMBRYONIC STEM CELLS; SIGNALING COMPONENTS; TYPE I INTERFERONS;

STEM CELLS;

ALPHA INTERFERON; BETA INTERFERON; GC PROTEIN; INITIATION FACTOR 2ALPHA; INTERFERON; OMEGA INTERFERON; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VIRUS PROTEIN; ALPHA BETA INTERFERON RECEPTOR; ANTIVIRUS AGENT; CYTOKINE; G1P2 PROTEIN, MOUSE; IFNAR1 PROTEIN, MOUSE; UBIQUITIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; INNATE IMMUNITY; ISG15 GENE; LA CROSSE VIRUS; MOUSE; NONHUMAN; OAS1 GENE; PKR GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RIG I GENE; SIGNAL TRANSDUCTION; SOCS1 GENE; TLR3 GENE; TRANSCRIPTION INITIATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION; WEST NILE FLAVIVIRUS; ANIMAL; CELL CULTURE; CELL LINE; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECTS; FIBROBLAST; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL LINE; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA VIRUS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC STEM CELLS; FIBROBLASTS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INTERFERON TYPE I; LA CROSSE VIRUS; MICE; MICROSCOPY, CONFOCAL; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITINS; VERO CELLS;

EID: 84906962772     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.537746     Document Type: Article

References (65)

1. Niwa, H. (2007) How is pluripotency determined and maintained? Development 134, 635-646
2. Wobus, A. M., and Boheler, K. R. (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635-678
3. Földes, G., Liu, A., Badiger, R., Paul-Clark, M., Moreno, L., Lendvai, Z., Wright, J. S., Ali, N. N., Harding, S. E., and Mitchell, J. A. (2010) innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS ONE 5, e10501
4. Zampetaki, A., Xiao, Q., Zeng, L., Hu, Y., and Xu, Q. (2006) TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem. Biophys. Res. Commun. 347, 89-99
5. Glaser, D. E., Gower, R. M., Lauer, N. E., Tam, K., Blancas, A. A., Shih, A. J., Simon, S. I., and McCloskey, K. E. (2011) Functional characterization of embryonic stem cell-derived endothelial cells. J. Vasc. Res. 48, 415-428
6. Rajan, S., Ye, J., Bai, S., Huang, F., and Guo, Y. L. (2008) NF-κB, but not p38 MAP kinase, is required for TNF-α-induced expression of cell adhesion molecules in endothelial cells. J. Cell. Biochem. 105, 477-486
7. Kawai, T., and Akira, S. (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650
8. Kato, H., Takahasi, K., and Fujita, T. (2011) RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 243, 91-98
9. Sen, G. C. (2001) Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281
10. Zampetaki, A., Zeng, L., Xiao, Q., Margariti, A., Hu, Y., and Xu, Q. (2007) Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-α is rescued by HDAC inhibitor trichostatin A. Am. J. Physiol. Cell Physiol. 293, C1226-C1238
11. Yu, J., Rossi, R., Hale, C., Goulding, D., and Dougan, G. (2009) Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect. Immun. 77, 585-597
12. Wash, R., Calabressi, S., Franz, S., Griffiths, S. J., Goulding, D., Tan, E.-P., Wise, H., Digard, P., Haas, J., Efstathiou, S., and Kellam, P. (2012) Permissive and restricted virus infection of murine embryonic stem cells. J. Gen. Virol. 93, 2118-2130
13. Wang, R., Wang, J., Paul, A. M., Acharya, D., Bai, F., Huang, F., and Guo, Y. L. (2013) Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J. Biol. Chem. 288, 15926-15936
14. Wang, R., Teng, C., Spangler, J., Wang, J., Huang, F., and Guo, Y.-L. (2014) Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy. Stem Cells Dev. 23, 594-604
15. Chen, L. L., Yang, L., and Carmichael, G. G. (2010) Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell Cycle 9, 3552-3564
16. González-Navajas, J. M., Lee, J., David, M., and Raz, E. (2012) Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12, 125-135
17. Samuel, C. E. (2001) Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809
18. Nallagatla, S. R., Hwang, J., Toroney, R., Zheng, X., Cameron, C. E., and Bevilacqua, P. C. (2007) 5′-Triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318, 1455-1458
19. Stetson, D. B., and Medzhitov, R. (2006) Type I interferons in host defense. Immunity 25, 373-381
20. Hong, X. X., and Carmichael, G. G. (2013) Innate immunity in pluripotent human cells: attenuated response to interferon-β. J. Biol. Chem. 288, 16196-16205
21. Bai, F., Wang, T., Pal, U., Bao, F., Gould, L. H., and Fikrig, E. (2005) Use of RNA interference to prevent lethal murine West Nile Virus infection. J. Infect. Dis. 191, 1148-1154
22. Torres, J., Prieto, J., Durupt, F. C., Broad, S., and Watt, F. M. (2012) Efficient differentiation of embryonic stem cells into mesodermal precursors by BMP, retinoic acid, and Notch signalling. PLoS ONE 7, e36405
23. Albers, J., Schulze, J., Beil, F. T., Gebauer, M., Baranowsky, A., Keller, J., Marshall, R. P., Wintges, K., Friedrich, F. W., Priemel, M., Schilling, A. F., Rueger, J. M., Cornils, K., Fehse, B., Streichert, T., Sauter, G., Jakob, F., Insogna, K. L., Pober, B., Knobeloch, K. P., Francke, U., Amling, M., and Schinke, T. (2011) Control of bone formation by the serpentine receptor Frizzled-9. J. Cell Biol. 192, 1057-1072
24. Dissing-Olesen, L., Thaysen-Andersen, M., Meldgaard, M., Højrup, P., and Finsen, B. (2008) The function of the human interferon-β1a glycan determined in vivo. J. Pharmacol. Exp. Ther. 326, 338-347
25. Kubes, M., Fuchsberger, N., and Kontsek, P. (1994) Cross-species antiviral and antiproliferative activity of human interferon-ω. J. Interferon Res. 14, 57-59
26. Guo, Y. L., Ye, J., and Huang, F. (2007) p38α MAP kinase-deficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons. Dev. Dyn. 236, 3383-3392
27. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
28. Guo, Y. L., Chakraborty, S., Rajan, S. S., Wang, R., and Huang, F. (2010) Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal. Stem Cells Dev. 19, 1321-1331
29. Wang, R., and Guo, Y. L. (2012) Transient inhibition of cell proliferation does not compromise self-renewal of mouse embryonic stem cells. Exp. Cell Res. 318, 2094-2104
30. Guo, Y. L., Kang, B., Yang, L. J., and Williamson, J. R. (1999) Tumor necrosis factor-α and ceramide induce cell death through different mechanisms in rat mesangial cells. Am. J. Physiol. 276, F390-F397
31. Streitenfeld, H., Boyd, A., Fazakerley, J. K., Bridgen, A., Elliott, R. M., and Weber, F. (2003) Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J. Virol. 77, 5507-5511
32. Elliott, R. M., and Weber, F. (2009) Bunyaviruses and the type I interferon system. Viruses 1, 1003-1021
33. Soldan, S. S., Hollidge, B. S., Wagner, V., Weber, F., and González-Scarano, F. (2010) La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology 404, 139-147
34. Schilte, C., Couderc, T., Chretien, F., Sourisseau, M., Gangneux, N., Guivel-Benhassine, F., Kraxner, A., Tschopp, J., Higgs, S., Michault, A., Arenzana-Seisdedos, F., Colonna, M., Peduto, L., Schwartz, O., Lecuit, M., and Albert, M. L. (2010) Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J. Exp. Med. 207, 429-442
35. Thon-Hon, V. G., Denizot, M., Li-Pat-Yuen, G., Giry, C., Jaffar-Bandjee, M. C., and Gasque, P. (2012) Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection. Virol. J. 9, 213
36. García, M. A., Meurs, E. F., and Esteban, M. (2007) The dsRNA protein kinase PKR: virus and cell control. Biochimie 89, 799-811
37. Skaug, B., and Chen, Z. J. (2010) Emerging role of ISG15 in antiviral immunity. Cell 143, 187-190
38. Stewart, W. E., 2nd., Gosser, L. B., and Lockart, R. Z., Jr. (1971) Priming: a nonantiviral function of interferon. J. Virol. 7, 792-801
39. Sadzak, I., Schiff, M., Gattermeier, I., Glinitzer, R., Sauer, I., Saalmüller, A., Yang, E., Schaljo, B., and Kovarik, P. (2008) Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc. Natl. Acad. Sci. U.S.A. 105, 8944-8949
40. Platanias, L. C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386
41. Stead, E., White, J., Faast, R., Conn, S., Goldstone, S., Rathjen, J., Dhingra, U., Rathjen, P., Walker, D., and Dalton, S. (2002) Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21, 8320-8333
42. Keller, G. (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129-1155
43. Reznikoff, C. A., Brankow, D. W., and Heidelberger, C. (1973) Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33, 3231-3238
44. Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., and Chaponnier, C. (2001) α-Smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12, 2730-2741
45. Paik, J. H., Skoura, A., Chae, S. S., Cowan, A. E., Han, D. K., Proia, R. L., and Hla, T. (2004) Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev. 18, 2392-2403
46. Darland, D. C., and D'Amore, P. A. (2001) TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 4, 11-20
47. Cheng, G., Liao, S., Kit Wong, H., Lacorre, D. A., di Tomaso, E., Au, P., Fukumura, D., Jain, R. K., and Munn, L. L. (2011) Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. Blood 118, 4740-4749
48. Chambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J., and Heller, R. A. (2003) Global expression profiling of fibroblast responses to transforming growth factor-β1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am. J. Pathol. 162, 533-546
49. Whyatt, L. M., Düwel, A., Smith, A. G., and Rathjen, P. D. (1993) The responsiveness of embryonic stem cells to α and β interferons provides the basis of an inducible expression system for analysis of developmental control genes. Mol. Cell. Biol. 13, 7971-7976
50. Ruffner, H., Reis, L. F., Näf, D., and Weissmann, C. (1993) Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc. Natl. Acad. Sci. U.S.A. 90, 11503-11507
51. Jordana, M., Särnstrand, B., Sime, P. J., and Ramis, I. (1994) Immuneinflammatory functions of fibroblasts. Eur. Respir. J. 7, 2212-2222
52. Smith-Arica, J. R., Thomson, A. J., Ansell, R., Chiorini, J., Davidson, B., and McWhir, J. (2003) Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells 5, 51-62
53. Kubo, M., Hanada, T., and Yoshimura, A. (2003) Suppressors of cytokine signaling and immunity. Nat. Immunol. 4, 1169-1176
54. Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., and Yokota, T. (1999) STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18, 4261-4269
55. Dahéron, L., Opitz, S. L., Zaehres, H., Lensch, M. W., Lensch, W. M., Andrews, P. W., Itskovitz-Eldor, J., and Daley, G. Q. (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22, 770-778
56. Humphrey, R. K., Beattie, G. M., Lopez, A. D., Bucay, N., King, C. C., Firpo, M. T., Rose-John, S., and Hayek, A. (2004) Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22, 522-530
57. Burdon, T., Smith, A., and Savatier, P. (2002) Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12, 432-438
58. Dalton, S. (2009) Exposing hidden dimensions of embryonic stem cell cycle control. Cell Stem Cell 4, 9-10
59. Singh, A. M., and Dalton, S. (2009) The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5, 141-149
60. Levy, O. (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379-390
61. Maillard, P. V., Ciaudo, C., Marchais, A., Li, Y., Jay, F., Ding, S. W., and Voinnet, O. (2013) Antiviral RNA interference in mammalian cells. Science 342, 235-238
62. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811
63. Pare, J. M., and Sullivan, C. S. (2014) Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog. 10, e1003865
64. Cullen, B. R., Cherry, S., and tenOever, B. R. (2013) Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 14, 374-378
65. Jeang, K. T. (2012) RNAi in the regulation of mammalian viral infections. BMC Biol. 10, 58